United Therapeutics Corp (UTHR)
237.04
+1.73
(+0.74%)
USD |
NASDAQ |
Apr 18, 16:00
236.92
-0.12
(-0.05%)
After-Hours: 20:00
United Therapeutics Market Cap: 11.15B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 11.15B |
| April 17, 2024 | 11.07B |
| April 16, 2024 | 10.91B |
| April 15, 2024 | 11.06B |
| April 12, 2024 | 10.95B |
| April 11, 2024 | 11.16B |
| April 10, 2024 | 11.19B |
| April 09, 2024 | 11.15B |
| April 08, 2024 | 11.15B |
| April 05, 2024 | 10.99B |
| April 04, 2024 | 11.01B |
| April 03, 2024 | 10.88B |
| April 02, 2024 | 10.76B |
| April 01, 2024 | 10.74B |
| March 28, 2024 | 10.81B |
| March 27, 2024 | 11.45B |
| March 26, 2024 | 11.66B |
| March 25, 2024 | 11.49B |
| March 22, 2024 | 11.20B |
| March 21, 2024 | 11.15B |
| March 20, 2024 | 11.14B |
| March 19, 2024 | 11.27B |
| March 18, 2024 | 11.01B |
| March 15, 2024 | 11.10B |
| March 14, 2024 | 11.21B |
| Date | Value |
|---|---|
| March 13, 2024 | 11.35B |
| March 12, 2024 | 11.62B |
| March 11, 2024 | 11.74B |
| March 08, 2024 | 11.44B |
| March 07, 2024 | 11.29B |
| March 06, 2024 | 11.15B |
| March 05, 2024 | 10.81B |
| March 04, 2024 | 10.76B |
| March 01, 2024 | 10.91B |
| February 29, 2024 | 10.62B |
| February 28, 2024 | 10.70B |
| February 27, 2024 | 10.67B |
| February 26, 2024 | 10.52B |
| February 23, 2024 | 10.68B |
| February 22, 2024 | 10.24B |
| February 21, 2024 | 10.31B |
| February 20, 2024 | 10.08B |
| February 16, 2024 | 10.10B |
| February 15, 2024 | 10.10B |
| February 14, 2024 | 10.09B |
| February 13, 2024 | 10.05B |
| February 12, 2024 | 10.17B |
| February 09, 2024 | 9.989B |
| February 08, 2024 | 9.960B |
| February 07, 2024 | 9.914B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.282B
Minimum
Jul 22 2019
12.78B
Maximum
Dec 09 2022
7.977B
Average
8.607B
Median
Market Cap Benchmarks
| Liquidia Corp | 1.050B |
| Esperion Therapeutics Inc | 346.01M |
| Vertex Pharmaceuticals Inc | 101.64B |
| Sarepta Therapeutics Inc | 10.94B |
| Heron Therapeutics Inc | 408.14M |
Market Cap Related Metrics
| PE Ratio | 11.95 |
| PS Ratio | 5.062 |
| PEG Ratio | 0.3723 |
| Price to Book Value | 1.864 |
| Price to Free Cash Flow | 15.76 |
| Price | 237.04 |
| Earnings Yield | 8.37% |
| PEGY Ratio | 0.3723 |
| Operating PE Ratio | 9.942 |
| Normalized PE Ratio | 11.95 |